IVF: A Numbers Game Made Worse by Rogue Clinics
By Loretta Houlahan,
The Age [Australia]
| 06. 10. 2015
Untitled Document
In a departure from the usual IVF miracle baby stories, much attention has been devoted recently to IVF success rates, or more specifically the lack thereof at some of Australia's worst-performing clinics. Pregnancy rates hover in the single digits at these places, and many industry insiders say the only miracle about these clinics is that they haven't been shut down. Debate has been raging about whether to publish a confidential league table that would name and shame these poor performers, give public recognition to high achievers, and allow patients to make an informed choice about where they spend their money.
As an embryologist for more than eight years, I know the ugly side of IVF in this country. Hidden behind the 12,000 babies born each year from assisted reproduction are the stories of people whose hopes, dreams and bank accounts have been shattered by unscrupulous and incompetent IVF providers. Adding insult to injury is how quick unsuccessful patients are to blame themselves instead of their underperforming clinics for failed IVF treatments and the lost chance of parenthood.
Each year a collaborative report...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...